Literature DB >> 989096

Proximal myopathy caused by latrogenic phosphate depletion.

M Ravid, M Robson.   

Abstract

Severe proximal myopathy associated with hypophosphatemia developed in three patients with chronic renal failure who had been treated with aluminum hydroxide gel. The syndrome was characterized by severe pain, muscular stiffness, and weakness. The illness was originally misdiagnosed both as uremic myopathy and as an exacerbation of rheumatoid arthritis. In one patient, the correct diagnosis was made when symptomatic relief corresponded to the rise of serum phosphate levels. Discontinuation of antacid therapy was followed by gradual recovery. Oral sodium phosphate brought prompt alleviation of muscular pain and stiffness.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 989096

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  15 in total

1.  Emergency Neurological Life Support: Acute Non-traumatic Weakness.

Authors:  Anna Finley Caulfield; Oliver Flower; Jose A Pineda; Shahana Uddin
Journal:  Neurocrit Care       Date:  2017-09       Impact factor: 3.210

2.  'Moderate' hypophosphatemia--not always an innocent bystander.

Authors:  R C Morris
Journal:  West J Med       Date:  1987-11

3.  Ion concentrations in serum and cerebrospinal fluid of patients with neuromuscular diseases.

Authors:  E Csenkér; P Diószeghy; I Fekete; F Mechler
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1982

4.  Reversible depression in myocardial performance in dogs with experimental phosphorus deficiency.

Authors:  T J Fuller; W W Nichols; B J Brenner; J C Peterson
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

5.  Defective adenosine triphosphate synthesis. An explanation for skeletal muscle dysfunction in phosphate-deficient mice.

Authors:  B D Hettleman; R L Sabina; M K Drezner; E W Holmes; J L Swain
Journal:  J Clin Invest       Date:  1983-08       Impact factor: 14.808

6.  A clinical approach to common electrolyte problems: 3. Hypophosphatemia.

Authors:  C Berkelhammer; R A Bear
Journal:  Can Med Assoc J       Date:  1984-01-01       Impact factor: 8.262

7.  Hypophosphatemia associated with coma.

Authors:  J L Lee; W J Sibbald; R L Holliday; A L Linton
Journal:  Can Med Assoc J       Date:  1978-07-22       Impact factor: 8.262

8.  Dialysis myopathy. Report of 13 cases.

Authors:  J Bautista; E Gil-Necija; J Castilla; I Chinchon; E Rafel
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

Review 9.  A comparative overview of the adverse effects of antiulcer drugs.

Authors:  D W Piper
Journal:  Drug Saf       Date:  1995-02       Impact factor: 5.606

10.  Adenosine triphosphate turnover in humans. Decreased degradation during relative hyperphosphatemia.

Authors:  M A Johnson; K Tekkanat; S P Schmaltz; I H Fox
Journal:  J Clin Invest       Date:  1989-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.